Skip to main content

A Non-Surgical Treatment to Restore Heart Valve Function

Project description

A simple, non-invasive treatment for a dangerous heart disease is on the way

The heart is a complex 4-chamber hydraulic system comprising pumps and valves. Normally, the tricuspid valve between the right atrium and ventricle opens to allow deoxygenated blood from the atrium into the ventricle. When the right ventricle contracts to pump the blood to the lungs for reoxygenation, the valve closes tightly to prevent blood from flowing backward. When the valve is damaged, the results can be lethal. Although severe tricuspid valve dysfunction is a highly prevalent condition, it has been relatively neglected. No longer the case, CVTVT has developed a device that can be delivered to the site non-invasively, restoring tricuspid valve function. Clinical trials and commercialisation will bring this simple life-saving device to patients.

Field of science

  • /social sciences/economics and business/business and management/commerce
  • /medical and health sciences/clinical medicine/surgery

Call for proposal

H2020-SMEInst-2018-2020-2
See other projects for this call

Funding Scheme

SME-2 - SME instrument phase 2

Coordinator

CROIVALVE LIMITED
Address
Unit A Gf, The Liffey Trust Centre, 117-125 Upper Sheriff Street
D01 Y0E7 Dublin
Ireland
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 2 494 970